ILXQuant Synthetic Biology and Bioeconomy Basket Index

Fixed-basket index of 10 companies at the vanguard of the biological revolution -- where DNA becomes a programming language and living organisms become manufacturing plants. The basket spans the full bioeconomy stack from organism engineering (Ginkgo Bioworks), synthetic DNA writing (Twist Bioscience), AI protein design (Recursion, Absci), long-read sequencing (Pacific Biosciences), the sequencing infrastructure (Illumina), bioprocessing equipment (Repligen), proteomics (Seer), tissue engineering (Organogenesis), and targeted protein degradation (Arvinas). Rebalances quarterly to equal weight. The convergence of AI and CRISPR is to the 2030s what semiconductor plus software was to the 1990s -- early and intentionally forward-leaning.

Index identifier
ILXSYN
Category
Basket
Universe
Fixed basket -- 10 synthetic biology and bioeconomy companies (equal weight)
Currency
USD
Inception
2021-12-06
Rebalancing
Quarterly (first Monday of March, June, September, December)
Index fee
0.60% p.a.
Reference benchmark
Health Care SPDR (XLV)

Performance and risk

All figures below are measured over a trailing window of up to 1,260 trading days (approximately five years), not since index inception.

Performance and risk — 2021-12-06 to 2026-08-13 00:00:00
Annualised return-15.44%
Sharpe ratio-0.29
Calmar ratio-0.20
Volatility53.05%
Maximum drawdown-76.92%
Return, 1 month
Return, 3 months
Return, 1 year
Return, year to date+22.98%

Full performance history, drawdown analysis, rolling risk metrics and portfolio breakdowns for this index are available in the ILX Quant platform.